
Lenskart Solutions Limited IPO
Lenskart Solutions Limited IPO is a Mainboard book building IPO. Issue size is 7,278.02 Cr. Price band is ₹382 to ₹402 per share. Minimum investment is ₹14,874. Lot size is 37 shares. Open from 31 Oct 2025 to 4 Nov 2025. Allotment on 6 Nov 2025. Listing on 10 Nov 2025 at BSE, NSE. Managed by Kotak Mahindra Capital Co.Ltd., Morgan Stanley India Co.Pvt.Ltd., Avendus Capital Pvt.Ltd., Citigroup Global Markets India Pvt.Ltd., Axis Capital Ltd., and Intensive Fiscal Services Pvt.Ltd. Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, allotment, and listing in one place.
Lenskart Solutions Limited IPO overview
Lenskart Solutions Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Lenskart Solutions Limited IPO important dates
Lenskart Solutions Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 37 | ₹14,874 |
| Retail (Max) | 13 | 481 | ₹1,93,362 |
| S-HNI (Min) | 14 | 518 | ₹2,08,236 |
| S-HNI (UPI) | 33 | 1,221 | ₹4,90,842 |
| S-HNI (Max) | 67 | 2,479 | ₹9,96,558 |
| B-HNI (Min) | 68 | 2,516 | ₹10,11,432 |
About Lenskart Solutions Limited IPO
From the company / RHP narrative.
Operating under a direct-to-consumer model, the company offers a broad range of eyewear under its own brands and sub-brands, catering to all age groups and price segments. In FY 2025, 105 new collections were launched, including collaborations with well-known brands and personalities.
As of March 31, 2025, Lenskart operated 2,723 stores globally—2,067 in India and 656 overseas—with 1,757 owned and 310 franchised stores in India. Remote eye testing is offered through 136 optometrists at 168 stores across India and select international locations, including Japan and Thailand.
Manufacturing is centralized in Bhiwadi and Gurugram, supported by regional facilities in Singapore and the UAE. This setup enables next-day delivery in 40 Indian cities and 3-day delivery in 69 cities for single-vision prescription eyewear.
The company posted revenues of ₹37,880.28 million, ₹54,277.03 million, and ₹66,525.17 million in FY 2023, 2024, and 2025 respectively, showing consistent year-on-year growth. Its apps have over 100 million cumulative downloads, with a tech team of 532 members.
Key strengths include:
Centralized supply chain and in-house manufacturing
In-house frame and lens engineering
Direct-to-consumer approach
Customer-centric product design
Owned eyewear brand portfolio
Technology-led operations and retail experience
Omnichannel retail presence
Multi-year revenue and EBITDA growth trajectory
Objective of the issue
How the issuer plans to use IPO proceeds.
Expenditure for lease/rent/license agreements related payments for our CoCo stores operated by the Company, in India
Investing in technology and cloud infrastructure
Brand marketing and business promotion expenses for enhancing brand awareness
Unidentified inorganic acquisitions and general corporate purposes
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow IPO & unlisted research in the app, available on iOS and Android.